SARS-CoV-2 (COVID-19) NSP13 (Helicase) Peptide
| Code | Size | Price |
|---|
| PSI-9181P-0.05mg | 0.05mg | £166.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Target Species: Virus
Application: Blocking
Storage:
Store SARS-CoV-2 (COVID-19) NSP13 (Helicase) Peptide at -20˚C, stable for one year.
Documents
Further Information
Additional Names:
Helicase, Non-structural protein 13, NSP13
Application Note:
SARS-CoV-2 (COVID-19) NSP13 (Helicase) Peptide is used for blocking the activity of the SARS-CoV-2 (COVID-19) NSP13 (Helicase) Antibody.
Background References:
- Gorbalenya. bioRxiv: 2020.
- Hui et al. Int J Infect Dis. 2020;91:264-266.
- Tanner et. al. J.Biol. Chem. 2003;278:39578-39582
Buffer:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Concentration:
200 ug/mL
NCBI Gene ID #:
43740578
NCBI Official Name:
ORF1a polyprotein;ORF1ab polyprotein
NCBI Official Symbol:
ORF1ab
NCBI Organism:
SARS-CoV-2 coronavirus
Peptide aa Location:
19 amino acids near the carboxyl terminus of the SARS-CoV-2 (COVID-19) NSP13 (Helicase) protein.
Physical State:
Liquid
Protein Accession #:
YP_009725308.1
Protein GI Number:
1802476816
Swissprot #:
P0DTC1